Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fallopian Tube Neoplasms × Acetaminophen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 12 Multiple Myeloma 11 Pain, Postoperative 9 Neoplasms 8 Agnosia 6 Lung Neoplasms 5 Cancer Pain 5 Breast Neoplasms 5 Neoplasm Metastasis 4 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Lymphoma 3 Head and Neck Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Trigger Finger Disorder 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Leukemia, Hairy Cell 2 Leukemia 2 Ganglion Cysts 2 Esophageal Neoplasms 2 De Quervain Disease 2 Colonic Neoplasms 2 Chronic Pain 2 Carcinoma in Situ 2 Burkitt Lymphoma 2

Interventions

Carboplatin 134 Paclitaxel 122 Bevacizumab 69 Gemcitabine 37 Taxes 36 liposomal doxorubicin 33 Cisplatin 30 pembrolizumab 29 Topotecan 27 olaparib 21 Cyclophosphamide 21 Specimen Handling 19 Immunoglobulin G 19 Disulfides 19 Drug Therapy 17 Docetaxel 17 Magnetic Resonance Spectroscopy 15 Doxorubicin 14 Biopsy 14 niraparib 13 mirvetuximab soravtansine 13 Hyperthermic Intraperitoneal Chemotherapy 12 Nivolumab 11 rucaparib 10 Cytoreduction Surgical Procedures 10 Chemotherapy, Adjuvant 10 Platinum 8 Neoadjuvant Therapy 8 Albumin-Bound Paclitaxel 8 veliparib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06824467 2026-03-13

TroFuse-022

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡